QDEL
QuidelOrtho Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$14.18
+1.81%Year over year
Reported trailing growth
- Revenue
- -2.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -4.2%
- EBITDA
- +238.0%
- EPS
- +105.6%
Three-year CAGR
- Revenue
- -5.8%
- EBITDA
- +67.2%
- EBIT
- +53.1%
- Net income
- +44.8%
- EPS
- +45.4%
- Free cash flow
- +26.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026